StudyHub

Construct a 5 pg  pp di**ussing each of the four traditional mood stabilizer medications: carbamazepine, lamotrigine, lithium, and valproate products. Support your answers with five (5) evidence-based, peer-reviewed scholarly literature

 

Struggling with where to start this assignment? Follow this guide to tackle your assignment easily!

---

Step-by-Step PowerPoint Guide: Traditional Mood Stabilizer Medications

---

Slide 1: Title Slide

Include the following:

• Title: Comparative Review of Traditional Mood Stabilizers

• Your name

• Course title

• Date

• Instructor’s name

---

Slide 2: Introduction

Briefly explain:

• What are mood stabilizers?

• Why are they used? (Primarily in bipolar disorder, to treat and prevent manic/depressive episodes)

• What will the audience learn? (Overview of four traditional medications)

Tip: Use 3–4 concise bullet points and a relevant graphic or diagram of mood regulation/neurotransmitters.

---

Slide 3: Lithium

Cover the following points:

• Mechanism of Action: Thought to modulate neurotransmitters and second messenger systems

• Indications: Bipolar disorder (mania and maintenance), treatment-resistant depression

• Dosage: Typically 600–1200 mg/day in divided doses; requires blood level monitoring (therapeutic range: 0.6–1.2 mEq/L)

• Side Effects: Tremor, hypothyroidism, weight gain, polyuria, potential toxicity

• Monitoring Needs: Kidney and thyroid function, serum lithium levels

Support this slide with one scholarly source such as:

Gitlin, M. (2016). Lithium side effects and toxicity: prevalence and management strategies. International Journal of Bipolar Disorders, 4(1), 27.

---

Slide 4: Valproate (Valproic Acid/Divalproex Sodium)

Cover:

• Mechanism of Action: Increases GABA availability; stabilizes mood via sodium channel blockade

• Indications: Bipolar disorder (acute mania), epilepsy, migraine prophylaxis

• Dosage: ~750–1500 mg/day; therapeutic level: 50–100 mcg/mL

• Side Effects: Weight gain, hair thinning, liver toxicity, pancreatitis, teratogenicity

• Monitoring Needs: Liver enzymes, platelet count, serum drug level

Support this slide with a source like:

Bowden, C. L. (2009). Valproate. Bipolar Disorders, 11(s2), 9–20.

---

Slide 5: Carbamazepine

Include:

• Mechanism of Action: Blocks voltage-gated sodium channels; modulates glutamate

• Indications: Bipolar disorder (especially manic/mixed episodes), trigeminal neuralgia, epilepsy

• Dosage: ~200–1200 mg/day; therapeutic level: 4–12 mcg/mL

• Side Effects: Dizziness, nausea, hyponatremia, agranulocytosis, liver enzyme induction

• Monitoring Needs: CBC, liver function tests, sodium, drug levels

Suggested citation:

Ketter, T. A., & Wang, P. W. (2003). Mood stabilizers in bipolar disorder: an overview. Journal of Clinical Psychiatry, 64(Suppl 5), 3–8.

---

Slide 6: Lamotrigine

Address:

• Mechanism of Action: Inhibits sodium channels and decreases glutamate release

• Indications: Bipolar depression maintenance (less effective for mania)

• Dosage: Titrated slowly to 100–200 mg/day to avoid rash

• Side Effects: Rash, including rare Stevens-Johnson syndrome, insomnia, dizziness

• Monitoring Needs: Watch for skin rash, assess drug interactions

Source idea:

Calabrese, J. R., et al. (2002). A double-blind placebo-controlled study of lamotrigine in rapid-cycling bipolar disorder. Journal of Clinical Psychiatry, 63(9), 841–850.

---

Slide 7: Comparison Table

Create a side-by-side chart comparing:

---

Slide 8: Conclusion

Wrap up by:

• Reiterating the importance of individualized treatment

• Noting that efficacy, safety, side effects, and monitoring needs differ

• Emphasizing the value of evidence-based prescribing

---

Slide 9: References

List all five (or more) peer-reviewed sources in APA format, such as:

1. Gitlin, M. (2016). International Journal of Bipolar Disorders, 4(1), 27.

2. Bowden, C. L. (2009). Bipolar Disorders, 11(s2), 9–20.

3. Ketter, T. A., & Wang, P. W. (2003). Journal of Clinical Psychiatry, 64(Suppl 5), 3–8.

4. Calabrese, J. R., et al. (2002). Journal of Clinical Psychiatry, 63(9), 841–850.

5. Geddes, J. R., et al. (2004). The Lancet, 363(9427), 201–217.

---

Final Tips:

• Keep slides clean and readable (max 6 bullet points per slide)

• Use high-quality visuals (diagrams, tables)

• Include speaker notes if required

• Cite your sources on each slide (author, year)

• Follow APA 7 formatting for references

The post Comparative Review of Traditional Mood Stabilizers in Bipolar Disorder Treatment appeared first on Skilled Papers.